• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】11996

【品名】1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine

【CA登记号】58-96-8

【 分 子 式 】C9H12N2O6

【 分 子 量 】244.20416

【元素组成】C 44.27% H 4.95% N 11.47% O 39.31%

与该中间体有关的原料药合成路线共 6 条

合成路线1

该中间体在本合成路线中的序号:(III)

Compound can be prepared in three different ways: 1) The reduction of cytidine (I) with H2 over Rh/Al2O3 in water in a Parr apparatus at 2.8 bar gives 3,4,5,6-tetrahydrocytidine (II), which is then hydrolyzed with water at pH 5.5. 2) The reduction of uridine (III) with H2 over Rh/Al2O3 as before gives 5,6-dihydrouridine (IV), which is then reduced again with NaBH4 in water or with H2 over Rh/Al2O3 in water containing ammonia. 3) The reduction of (III) can also be performed in a single step with H2 over Rh/Al2O3 in water containing NH3, in a Parr apparatus at 2.94 bar.

1 Woodman, R.J.; Tetrahydrouridine. Drugs Fut 1979, 4, 4, 283.
2 Hanze, A.R.; Nucleic acids. IV. The catalytic reduction of pyrimidine nucleosides (human liver deaminase inhibitors). J Am Chem Soc 1967, 89, 25, 6720-25.
3 Hanze, A.R.; Camiener, G.W.; US 3462416 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 27920 Cytidine; 4-amino-1-((2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone 65-46-3 C9H13N3O5 详情 详情
(II) 39509 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]tetrahydro-2(1H)-pyrimidinone C9H17N3O5 详情 详情
(III) 11996 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine 58-96-8 C9H12N2O6 详情 详情
(IV) 39510 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]dihydro-2,4(1H,3H)-pyrimidinedione C9H14N2O6 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

A new synthesis of 2',3'-dideoxyadenosine has been described: The reaction of uridine (I) with methyl orthoformate and p-toluenesulfonic acid gives the cyclic orthoester (II), which is acetylated with acetic anhydride at 100 C to the acetate (III). The reaction of (III) with acetic anhydride at temperatures over 120 C yields 5'-O-acetyl-2',3'-dideoxy-2',3'-didehydrouridine (IV), which is hydrogenated to 5'-O-acetyl-2',3'-dideoxyuridine (V).

1 Shiragami, H.; Shirae, H.; Irie, Y.; Yokozeki, K.; Yasuda, N.; The synthesis of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine. Nucl Acid Res Symp Ser 1988, 20, 20, 17-18.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11996 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine 58-96-8 C9H12N2O6 详情 详情
(I) 12001 1-[(2R,5S)-5-(Hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione 5983-09-5 C9H12N2O4 详情 详情
(II) 11997 1-[(3aR,4R,6R,6aR)-6-(Hydroxymethyl)-2-methoxytetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-2,4(1H,3H)-pyrimidinedione C11H14N2O7 详情 详情
(III) 11998 [(3aR,4R,6R,6aR)-6-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]-2-methoxytetrahydrofuro[3,4-d][1,3]dioxol-4-yl]methyl acetate C13H16N2O8 详情 详情
(IV) 11999 [(2S,5R)-5-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]-2,5-dihydro-2-furanyl]methyl acetate C11H12N2O5 详情 详情
(V) 12000 [(2S,5R)-5-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-2-furanyl]methyl acetate C11H14N2O5 详情 详情
(VI) 12001 1-[(2R,5S)-5-(Hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione 5983-09-5 C9H12N2O4 详情 详情
(VII) 10343 9H-Purin-6-amine; 9H-Purin-6-ylamine; Adenine 73-24-5 C5H5N5 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

2) The reaction of uridine (I) with methyl orthoformate and p-toluenesulfonic acid gives the cyclic orthoester (II), which is acetylated with acetic anhydride at 100 C, yielding the 5'-acetoxy derivative (III). The reaction of (III) with acetic anhydride at temperatures over 120 C affords 5'-O-acetyl-2',3'-dideoxy-2',3'-didehydrouridine (IV), which is hydrogenated to 5'-O-acetyl-2',3'-dideoxyuridine (V). Hydrolysis of (V) affords 2',3'-dideoxyuridine (VI), which is finally submitted to a transdideoxyribosylation with hypoxanthine (VII) by incubation in an appropriate medium with Escherichia coli AJ 2595 resting cells.

1 Shiragami, H.; Shirae, H.; Irie, Y.; Yokozeki, K.; Yasuda, N.; The synthesis of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine. Nucl Acid Res Symp Ser 1988, 20, 20, 17-18.
2 Shirae, H.; Kobayashi, K.; Shiragami, H.; Irie, Y.; Yasuda, N.; Yokozeki, K.; Production of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine from 2',3'-dideoxyuridine and the corresponding purine bases by resting cells of Escherichia coli AJ 2595. Appl Environ Microbiol 1989, 55, 2, 419-24.
3 Prous, J.; Castaner, J.; DIDEOXYINOSINE. Drugs Fut 1990, 15, 6, 569.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
60593 p-xylene C8H10 详情 详情
(I) 11996 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine 58-96-8 C9H12N2O6 详情 详情
(II) 11997 1-[(3aR,4R,6R,6aR)-6-(Hydroxymethyl)-2-methoxytetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-2,4(1H,3H)-pyrimidinedione C11H14N2O7 详情 详情
(III) 11998 [(3aR,4R,6R,6aR)-6-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]-2-methoxytetrahydrofuro[3,4-d][1,3]dioxol-4-yl]methyl acetate C13H16N2O8 详情 详情
(IV) 11999 [(2S,5R)-5-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]-2,5-dihydro-2-furanyl]methyl acetate C11H12N2O5 详情 详情
(V) 12000 [(2S,5R)-5-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-2-furanyl]methyl acetate C11H14N2O5 详情 详情
(VI) 12001 1-[(2R,5S)-5-(Hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione 5983-09-5 C9H12N2O4 详情 详情
(VII) 12794 9H-Purin-6-ol; Hypoxanthine 68-94-0 C5H4N4O 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

The acetylation of uridine (I) with acetic anhydride gives the 2',3',5'-triacetyl derivative (II), which is treated with SOCl2 and sodium ethoxide yielding the 4-ethoxypyrimidinone (III). The partial protection of (III) with 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (IV) yields the silylated compound (V), which is oxidized with oxalyl chloride to the silylated furanone (VI). The reaction of (VI) with fluoromethyl phenyl sulfone (A) by means of diethyl chlorophosphate (B) and lithium hexamethyldisylazide in THF affords the fluorovinyl sulfone (VII) as a mixture of (E) and (Z) isomers that is separated by flash chromatography. The (Z)-isomer (VII) is treated with tributyl tin hydride and AIBN in refluxing benzene to give the fluorovinyl stannane (VIII), which is finally treated with CsF and NH3 in refluxing methanol to afford the target compound.

1 Sunkara, P.S.; McCarthy, J.R.; Matthews, D.P.; et al.; Design of a fluoro-olefin cytidine nucleoside as a bioprecursor of a mechanism-based inhibitor of ribonucleotide reductase. ACS Symp Ser 1996, 639, 246.
2 McCarthy, J.R.; et al.; Stereospecific synthesis of 1-fluoro olefins via (fluorovinyl)stannanes and an unequivocal NMR method for the assignment of fluoro olefin geometry. Tetrahedron 1996, 52, 1, 45.
3 Matthews, D.P.; et al.; Improved synthesis of (E)-2'-deoxy-2'-(fluoromethylene)cytidine - A potent inhibitor of ribonucleotide diphosphate reductase. Nucleosides Nucleotides 1993, 12, 2, 115.
4 McCarthy, J.R.; Edwards, M.L.; Matthews, D.P. (Merrell Pharmaceuticals, Inc.); Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivs.. EP 0372268; JP 1990178272; US 5378693 .
5 McCarthy, J.R.; Matthews, D.P.; Bitonti, A.J.; Edwards, M.L. (Merrell Pharmaceuticals, Inc.); Treatment of carcinoma by administration of 2'-halomethylidenyl-2'-deoxynucleosides. US 5607925 .
6 McCarthy, J.R.; Matthews, D.P.; Edwards, M.L. (Merrell Pharmaceuticals, Inc.); 2'-Ethenylidene cytidine, uridine and guanosine derivs.. US 5616702 .
7 McCarthy, J.R.; et al.; Stereospecific method to E and Z terminal fluoro olefins and its application to the synthesis of 2'-deoxy-2'-fluoromethylene nucleosides as potential inhibitors of ribonucleoside diphosphate reductase. J Am Chem Soc 1991, 113, 19, 7439.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 23623 Chlorophosphoric acid ethyl ester;Phosphorochloridic acid diethyl ester;Diethyl chlorophosphate;diethyl phosphorochloridate 814-49-3 C4H10ClO3P 详情 详情
(A) 29245 (fluoromethyl)(dioxo)phenyl-lambda(6)-sulfane 20808-12-2 C7H7FO2S 详情 详情
(I) 11996 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine 58-96-8 C9H12N2O6 详情 详情
(II) 29248 (2R,3R,4R,5R)-4-(acetoxy)-2-[(acetoxy)methyl]-5-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-3-furanyl acetate C15H18N2O9 详情 详情
(III) 29249 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-4-ethoxy-2(1H)-pyrimidinone C11H16N2O6 详情 详情
(IV) 29242 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane 69304-37-6 C12H28Cl2OSi2 详情 详情
(V) 29250 1-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-4-ethoxy-2(1H)-pyrimidinone C23H42N2O7Si2 详情 详情
(VI) 29251 1-[(6aR,8R,9aR)-2,2,4,4-tetraisopropyl-9-oxotetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-4-ethoxy-2(1H)-pyrimidinone C23H40N2O7Si2 详情 详情
(VII) 29252 1-[(6aR,8R,9aS)-9-[(Z)-fluoro(phenylsulfonyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-ethoxy-2(1H)-pyrimidinone C30H45FN2O8SSi2 详情 详情
(VIII) 29253 1-[(6aR,8R,9aS)-9-[(Z)-fluoro(tributylstannyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-ethoxy-2(1H)-pyrimidinone C36H67FN2O6Si2Sn 详情 详情

合成路线5

该中间体在本合成路线中的序号:(IV)

INS-365 can also been obtained by the following ways: 4) Dimerization of uridine-5'-monophosphate tributyl-ammonium salt (I) with bis(tributylammonium) pyrophosphate (II) by means of CDI, followed by purification by semipreparative ion­exchange chromatography. 5) Dimerization of uridine-5'-monophosphate tributyl-ammonium salt (I) with pyrophosphoryl chloride (III) in pyridine, followed by chromatographic purification as before. 6) Condensation of uridine (IV) with POCl3 and bis(tributylammonium) pyrophosphate (II) by means of tributylamine in trimethyl phosphate, followed by chromatographic purification as before. 7) Dimerization of uridine-5'-diphosphate tributylammonium salt (V) by means of CDI in DMF, followed by purification over Dowex 50Wx4 Na+. 8) Condensation of uridine-5'-triphosphate tributylammonium salt (VI) with uridine-5'-monophosphate tributyl-ammonium salt (I) by means of DCC in DMF, followed by chromatographic purification as before. 9) Reaction of uridine-5'-monophosphate tributylammonium salt (I) with CDI in DMF, followed by condensation with uridine-5'-triphosphate (VI) and chromatographic purification as before.

1 Yerxa, B.J.; Pendergast, W. (Inspire Pharmaceuticals, Inc.); Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof. JP 2001510484; WO 9905155 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 47688   C21H40N3O9P 详情 详情
(II) 47695 di(N,N-dibutyl-1-butanaminium) 1,3-dihydroxy-1,3-dioxo-1lambda(5),3lambda(5)-diphosphoxane-1,3-diolate C24H58N2O7P2 详情 详情
(III) 47694 Pyrophosphoric tetrachloride Cl4O3P2 详情 详情
(IV) 11996 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine 58-96-8 C9H12N2O6 详情 详情
(V) 47690   C33H68N4O12P2 详情 详情
(VI) 47692   C45H96N5O15P3 详情 详情

合成路线6

该中间体在本合成路线中的序号:(I)

 

1 Krmitsky TA. 1988. Antiviral compounds. EP 0294114[本专利为GlaxoSmithKline (GB)所有]
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11996 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine 58-96-8 C9H12N2O6 详情 详情
(II) 66535 (2R,3S,3aS,9aR)-3-hydroxy-2-(hydroxymethyl)-3,3a-dihydro-2H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6(9aH)-one   C9H10N2O5 详情 详情
(III) 38235 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione C9H12N2O6 详情 详情
Extended Information